世界の副腎皮質ステロイド阻害剤市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP02190)
◆英語タイトル:Global Adrenal Corticosteroid Inhibitors Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP02190
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月18日(※2024年版があります。お問い合わせください。)
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、副腎皮質ステロイド阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。副腎皮質ステロイド阻害剤の種類別市場規模(オシロドロスタット、メチラポン)、用途別市場規模(病院、在宅医療、専門センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Novartis、Recordati、HRA Pharma
・地域別グローバル市場分析 2015年-2020年
・副腎皮質ステロイド阻害剤の北米市場(アメリカ、カナダ、メキシコ)
・副腎皮質ステロイド阻害剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・副腎皮質ステロイド阻害剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・副腎皮質ステロイド阻害剤の南米市場(ブラジル、アルゼンチン)
・副腎皮質ステロイド阻害剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:オシロドロスタット、メチラポン
・用途別分析:病院、在宅医療、専門センター、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Adrenal Corticosteroid Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Adrenal Corticosteroid Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Adrenal Corticosteroid Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Adrenal Corticosteroid Inhibitors market has been segmented into:
Osilodrostat
Metyrapone

By Application, Adrenal Corticosteroid Inhibitors has been segmented into:
Hospitals
Home Care
Speciality Centres
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adrenal Corticosteroid Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Adrenal Corticosteroid Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adrenal Corticosteroid Inhibitors market.

The report offers in-depth assessment of the growth and other aspects of the Adrenal Corticosteroid Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Adrenal Corticosteroid Inhibitors Market Share Analysis
Adrenal Corticosteroid Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Adrenal Corticosteroid Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adrenal Corticosteroid Inhibitors sales, revenue and market share for each player covered in this report.

The major players covered in Adrenal Corticosteroid Inhibitors are:
Novartis
Recordati
HRA Pharma
Among other players domestic and global, Adrenal Corticosteroid Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Adrenal Corticosteroid Inhibitors Market Overview
1.1 Product Overview and Scope of Adrenal Corticosteroid Inhibitors
1.2 Classification of Adrenal Corticosteroid Inhibitors by Type
1.2.1 Global Adrenal Corticosteroid Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Type in 2019
1.2.3 Osilodrostat
1.2.4 Metyrapone
1.3 Global Adrenal Corticosteroid Inhibitors Market by Application
1.3.1 Overview: Global Adrenal Corticosteroid Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Home Care
1.3.4 Speciality Centres
1.3.5 Others
1.4 Global Adrenal Corticosteroid Inhibitors Market by Regions
1.4.1 Global Adrenal Corticosteroid Inhibitors Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Adrenal Corticosteroid Inhibitors (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Adrenal Corticosteroid Inhibitors Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Adrenal Corticosteroid Inhibitors Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adrenal Corticosteroid Inhibitors Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Adrenal Corticosteroid Inhibitors Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adrenal Corticosteroid Inhibitors Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Adrenal Corticosteroid Inhibitors Revenue, Gross Margin and Market Share (2018-2019)
2.2 Recordati
2.2.1 Recordati Details
2.2.2 Recordati Major Business
2.2.3 Recordati SWOT Analysis
2.2.4 Recordati Product and Services
2.2.5 Recordati Adrenal Corticosteroid Inhibitors Revenue, Gross Margin and Market Share (2018-2019)
2.3 HRA Pharma
2.3.1 HRA Pharma Details
2.3.2 HRA Pharma Major Business
2.3.3 HRA Pharma SWOT Analysis
2.3.4 HRA Pharma Product and Services
2.3.5 HRA Pharma Adrenal Corticosteroid Inhibitors Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Adrenal Corticosteroid Inhibitors Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Adrenal Corticosteroid Inhibitors Players Market Share
3.2.2 Top 10 Adrenal Corticosteroid Inhibitors Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Adrenal Corticosteroid Inhibitors Revenue and Market Share by Regions
4.2 North America Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
4.3 Europe Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
4.5 South America Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
5 North America Adrenal Corticosteroid Inhibitors Revenue by Countries
5.1 North America Adrenal Corticosteroid Inhibitors Revenue by Countries (2015-2020)
5.2 USA Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
5.3 Canada Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
5.4 Mexico Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
6 Europe Adrenal Corticosteroid Inhibitors Revenue by Countries
6.1 Europe Adrenal Corticosteroid Inhibitors Revenue by Countries (2015-2020)
6.2 Germany Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
6.3 UK Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
6.4 France Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
6.5 Russia Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
6.6 Italy Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Adrenal Corticosteroid Inhibitors Revenue by Countries
7.1 Asia-Pacific Adrenal Corticosteroid Inhibitors Revenue by Countries (2015-2020)
7.2 China Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
7.3 Japan Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
7.4 Korea Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
7.5 India Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
8 South America Adrenal Corticosteroid Inhibitors Revenue by Countries
8.1 South America Adrenal Corticosteroid Inhibitors Revenue by Countries (2015-2020)
8.2 Brazil Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
8.3 Argentina Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Adrenal Corticosteroid Inhibitors by Countries
9.1 Middle East & Africa Adrenal Corticosteroid Inhibitors Revenue by Countries (2015-2020)
9.2 Saudi Arabia Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
9.3 UAE Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
9.4 Egypt Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
9.5 South Africa Adrenal Corticosteroid Inhibitors Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Adrenal Corticosteroid Inhibitors Revenue and Market Share by Type (2015-2020)
10.2 Global Adrenal Corticosteroid Inhibitors Market Forecast by Type (2019-2024)
10.3 Osilodrostat Revenue Growth Rate (2015-2025)
10.4 Metyrapone Revenue Growth Rate (2015-2025)
11 Global Adrenal Corticosteroid Inhibitors Market Segment by Application
11.1 Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Application (2015-2020)
11.2 Adrenal Corticosteroid Inhibitors Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Home Care Revenue Growth (2015-2020)
11.5 Speciality Centres Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Adrenal Corticosteroid Inhibitors Market Size Forecast (2021-2025)
12.1 Global Adrenal Corticosteroid Inhibitors Market Size Forecast (2021-2025)
12.2 Global Adrenal Corticosteroid Inhibitors Market Forecast by Regions (2021-2025)
12.3 North America Adrenal Corticosteroid Inhibitors Revenue Market Forecast (2021-2025)
12.4 Europe Adrenal Corticosteroid Inhibitors Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Adrenal Corticosteroid Inhibitors Revenue Market Forecast (2021-2025)
12.6 South America Adrenal Corticosteroid Inhibitors Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Adrenal Corticosteroid Inhibitors Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Novartis、Recordati、HRA Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の副腎皮質ステロイド阻害剤市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Adrenal Corticosteroid Inhibitors Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。